Find Academic Supervisors

• Cancer and Oncology
• Surgery
• Urology
• +3 more

Professor Peter Wiklund is a Senior Physician and academic at Karolinska Institutet, affiliated with the Department of Molecular Medicine and Surgery. His research focuses on urological oncology, particularly prostate and bladder cancers, with a strong emphasis on surgical innovations like robotic-assisted procedures and molecular diagnostics. He leads the Urology research group within Olof Akre's team, contributing to advancements in precision medicine and surgical outcomes. Research interests include robotic surgery outcomes for radical cystectomy and prostatectomy, biomarker development (e.g., circulating tumor DNA), and optimizing therapies for non-muscle-invasive bladder cancer. His work spans clinical trials and translational research, addressing complications, oncological efficacy, and patient quality of life. Recent publications highlight advancements in robotic surgical techniques, biomarker utilization, and comparative efficacy of treatments like BCG vs. chemotherapy regimens. His contributions span high-impact journals such as *European Urology*, *BJU International*, and *World Journal of Urology*.

• Immunology
• Cancer Immunology
• Primary Immunodeficiency
• +4 more

Malin Winerdal is a Researcher at Karolinska Institutet's Department of Laboratory Medicine, affiliated with the Division of Clinical Immunology and the Peter Bergman Research Group (AMP-group). Her work focuses on clinical immunology with emphasis on primary immunodeficiency, innate immunity, antimicrobial peptides, and cancer immunology. Her academic background includes: Doctor of Philosophy (PhD), Department of Medicine, Solna (2015) University Medical Degree (2008) Dr. Winerdal's research centers on immune mechanisms in urinary bladder cancer, particularly regulatory T cells and B cell interactions within the tumor microenvironment. She investigates how neoadjuvant chemotherapy modulates antitumor immunity, the role of FOXP3 in Treg functionality, and pathways of immune suppression like ICAM-1/TGFβ2-mediated perforin inhibition. Her work extends to neonatal brain injury and adenosine receptor signaling in hypertension, demonstrating a multidisciplinary approach to immunological mechanisms across disease contexts. Using techniques including flow cytometry, epigenetic analysis, and murine models, she bridges basic science with clinical applications in immunology. Analysis of her 15 most recent publications (2008-2021) reveals a dominant focus on bladder cancer immunology (75% of articles), with recurring themes of T cell regulation, tumor microenvironment dynamics, and immune checkpoint mechanisms. Secondary research streams include neonatal neuroprotection (13%) and cardiovascular immunology (12%), showcasing methodological versatility across in vitro, murine, and clinical human studies. Her collaborative work consistently involves Karolinska Institutet's urology and immunology departments, with Peter Bergman and Ola Winqvist as frequent co-investigators. She actively contributes to the AMP-group's mission of investigating innate immunity and antimicrobial peptides in primary immunodeficiencies, participating in both basic research and clinical outreach initiatives within Karolinska Institutet's immunology division.

Sebastian AlbinssonView profile

Senior Lecturer

• Vascular Physiology
• Smooth Muscle Biology
• MicroRNA Research
• +3 more

Sebastian Albinsson is a Senior Lecturer and Molecular Vascular Physiology Researcher at Lund University's Faculty of Medicine. He holds roles as Research Team Manager, Course Director, and Principal Investigator within the EXODIAB: Excellence of Diabetes Research in Sweden initiative. His work contributes to UN Sustainable Development Goals focused on health and well-being. Research Interests: Albinsson specializes in vascular physiology, smooth muscle biology, and the role of microRNAs in cardiovascular disease. His research explores hypertension mechanisms, aneurysm development, and molecular pathways regulating vascular smooth muscle function. Key focuses include YAP/TAZ signaling, actin cytoskeleton dynamics, and transcription factor-driven processes in vascular pathology. Recent Article Trends: Recent work emphasizes genome sequencing in heart failure, YAP/TAZ regulation in vascular mechanotransduction, and microRNA-driven lipid accumulation. These studies highlight translational applications in precision medicine and disease prevention. Grants & Projects: Exploring the relationship between metabolic vascular disease, smooth muscle mechanosensing and vascular ageing (2025–2026) Kan blodkärlens sträcksenor skydda mot aneurysm? (2024–2026) Advising: Supervised 8 research works, focusing on vascular biology and molecular mechanisms. Labs/Teams: Active in EXODIAB and the Molecular Vascular Physiology group, collaborating internationally on cardiovascular and diabetes research.

Ines AmbiteView profile

Researcher

• Urinary Tract Infections
• Cancer Immunotherapy
• Transcriptional Regulation
• +7 more

Ines Ambite is an Associate Researcher at the Division of Microbiology, Immunology and Glycobiology (MIG) and Medical Microbiology at Lund University, with affiliations to Infect@LU. Her work bridges urinary tract infections and cancer treatment response , focusing on transcriptional control mechanisms through translational molecular research. Key affiliations: Division of MIG, Medical Microbiology, Infect@LU Email: ines.ambite@med.lu.se Research emphasizes immunomodulatory therapies for infection and oncology, leveraging proteomics and molecular pathways. Recent publications highlight: ER remodeling in tumor cells Innate/adaptive immune imbalance in pyelonephritis Multitarget inhibition of MYC by bacterial proteases Alpha1-oleate clinical trials in bladder cancer Comparative analyses of immunotherapies Her work aligns with UN Sustainable Development Goals for global health advancement.

• Pediatric Infectious Diseases
• Neurology
• Clinical Diagnostics
• +3 more

Barbro Hedin Skogman is a Research Fellow at the Center for Clinical Research Dalarna , affiliated with Uppsala University . Her work focuses on pediatric infectious diseases and neurological manifestations of Lyme neuroborreliosis , with additional contributions to urinary disorders in children. Institution: Uppsala University Sub-unit: Center for Clinical Research Dalarna Academic rank: Research Fellow Her research spans Lyme neuroborreliosis diagnostics, biomarker evaluation, and clinical outcomes in children. Recent publications highlight her efforts in developing diagnostic tools like the NeBoP score and BABITT questionnaire , alongside exploring corticosteroid therapies for neurological complications. Current studies emphasize longitudinal clinical outcomes (2025), urinary and bowel function assessments (2025), and biomarker validation (2022). Collaborative work includes multicenter trials on facial nerve palsy (2021) and systematic reviews of tick-borne infection diagnostics (2021). Contact details: barbro.hedinskogman@uu.se , barbro.hedinskogman@regiondalarna.se . Address: Center for Clinical Research Dalarna, Nissers väg 3, 791 82 Falun, Sweden.

• Endocrinology and Diabetes
• Cell and Molecular Biology
• Diabetes Research
• +3 more

Kerstin Brismar is a Professor of Diabetes Research at Karolinska Institutet, part of the Department of Molecular Medicine and Surgery. She leads the Growth and Metabolism research group within the Rolf Luft Research Center for Diabetes and Endocrinology. Her work focuses on diabetes pathophysiology, metabolic disorders, and lifestyle interventions, particularly the 5:2 diet's impact on cardiometabolic health. She holds a Docent degree from Karolinska Institutet (1989) and has authored books like Koll på diabetes typ 2 and Lev länge & väl , emphasizing public outreach in diabetes management. Research Group: Growth and Metabolism (Sergiu-Bogdan Catrina) Affiliations: BioClinicum J8:20, Solna Key research interests include endocrinology, molecular mechanisms of diabetes complications, and translational studies linking metabolism to cardiovascular risk. Her studies frequently examine biomarkers like adiponectin, IGFBP proteins, and vitamin D. Publications highlight interventions targeting insulin resistance, dietary patterns, and genetic contributors to kidney dysfunction in diabetes. She collaborates on trials like the Sophia Step Study, exploring physical activity self-management in diabetes populations.

Madeleine WinbergView profile

Part-Time Lecturer

• Evidence-Based Practice
• Healthcare Implementation
• Orthopedic Nursing
• +3 more

Madeleine Winberg serves as a doctoral student and part-time lecturer at Linköping University's Faculty of Medicine within the Department of Nursing and Reproductive Health (ORH), part of the Department of Health, Medicine and Care (HMV). Her work bridges evidence-based healthcare implementation with clinical orthopedic practice, specifically targeting urinary retention prevention in hip surgery patients through the national OPTION research project. Her educational background includes a 2023 Bachelor of Science in Medical Sciences, 2007 Master's in Occupational Therapy, and 2003 Bachelor's in Occupational Therapy, all from Linköping University. She actively teaches in both the occupational therapy program and the master's course on Implementation in Healthcare. Winberg's research centers on closing the evidence-practice gap in orthopedic nursing through mixed-methods investigations of implementation barriers, patient experiences, and contextual factors. Her work emphasizes frontline leadership, pandemic-related adaptations, and patient-centered bladder care protocols, with a strong focus on qualitative analysis of healthcare delivery systems. Recent publications reveal a consistent trajectory examining how multiprofessional teams can overcome systemic obstacles to evidence-based care in surgical settings. Her 12 most recent publications (2021-2025) demonstrate evolving expertise in implementation science, with increasing emphasis on equity-focused interventions, pandemic-driven leadership adaptations, and multicentre validation of urinary retention prevention protocols. Key themes include the critical role of contextual awareness in guideline adherence and the necessity of patient perspectives in shaping evidence-based care pathways. As part of the OPTION research initiative, Winberg collaborates with Professor Ann Catrine Eldh and multidisciplinary teams to evaluate facilitation strategies for evidence-based guideline adoption. Her work involves coaching local clinical teams in knowledge translation within orthopedic rehabilitation contexts, specifically targeting urinary retention prevention through structured implementation frameworks that account for both evidence and contextual realities.

• Functional purinergic signalling
• Smooth muscle inflammation
• Urinary bladder function
• +3 more

Patrik Aronsson is a researcher and Associate Professor (docent) in Pharmacology at the University of Gothenburg 's Sahlgrenska Academy , Department of Pharmacology. He leads the Autonomic Neuroscience Unit and serves as Head of the Pharmacy Programme and Chairman of the Education Board for the Pharmacy Programme . He also coordinates supplementary education for non-EU pharmacists and teaches pharmacology across multiple programs. Research Focus: Functional purinergic signalling in smooth muscle Inflammation and remodeling in urinary bladder and prostate Neural control of micturition and cardiovascular function Pharmacology education and curriculum development His recent work spans in vitro and in vivo rodent models of chronic pelvic pain, prostatitis, and ketamine-induced uropathy, alongside global initiatives to define core pharmacology concepts and improve assessment tools. Publications Trend: A steady stream of high-impact papers (2021-2025) in Neurourology and Urodynamics , Scientific Reports , Frontiers in Physiology , and British Journal of Pharmacology reveals a dual focus on mechanistic studies of bladder/prostate pathophysiology and innovative educational research. Scientific Awards & Recognition: While specific awards are not listed, his editorial roles, leadership of international consensus meetings (ICI-RS), and coordination of global educational initiatives underscore significant peer recognition. Teaching & Advising: Course leader and examiner for FLS533 (Pharmacology, Medicinal Chemistry & Pathology) Member, Council for Education (first and second cycle programmes) Pharmacy Programme leadership and curriculum oversight Laboratory & Teams: Aronsson heads the Autonomic Neuroscience Unit within the Department of Pharmacology, fostering collaborative projects on smooth muscle biology, neuro-uropharmacology, and educational innovation.

Mona-Lisa WernrothView profile

Researcher

• Epidemiology
• Diabetes Research
• Cardiovascular Research
• +3 more

Mona-Lisa Wernroth serves as a Statistician at both the UCR-Uppsala Clinical Research center and the Department of Medical Sciences (Molecular Epidemiology) within the Faculty of Medicine at Uppsala University, Sweden. Her dual institutional appointments reflect her collaborative role across clinical research and academic departments, with physical locations at Dag Hammarskjölds väg 38 and EpiHubben, Dag Hammarskjölds väg 14B in Uppsala. Dr. Wernroth's research spans epidemiology, diabetes, cardiovascular health, and gut microbiota development, with specialization in Swedish register-based cohort studies. Her work consistently examines environmental exposures and their relationship to disease outcomes, particularly focusing on type 1 diabetes etiology and complications. She employs advanced statistical methodologies to analyze large population datasets, contributing significantly to understanding disease risk factors and comorbidities. Analysis of her 15 most recent publications (2017-2025) reveals a strong emphasis on epidemiological methods applied across multiple medical domains. Her research demonstrates methodological consistency while addressing diverse clinical questions, from renal function and cardiovascular outcomes to psychiatric comorbidities and microbial influences on health. The longitudinal nature of her work provides valuable insights into disease development and risk prediction.